Bio-Rad Laboratories, Inc. (BIO)

Bio-Rad Laboratories Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	2,671	2,802	2,923	2,546	2,312
Revenue Growth (YoY)	-4.67%	-4.12%	14.81%	10.12%	0.97%
Cost of Revenue	1,244	1,235	1,284	1,108	1,055
Gross Profit	1,427	1,567	1,638	1,438	1,257
Selling, General & Admin	841.72	827.83	877.12	798.8	824.63
Research & Development	247.43	256.89	260.64	217.76	202.71
Operating Expenses	1,089	1,085	1,138	1,017	1,027
Operating Income	337.8	482.62	500.34	421.33	229.66
Interest Expense / Income	49.44	38.11	1.55	21.86	23.42
Other Expense / Income	1,138	5,149	-4,950.27	-4,518.54	-2,054.84
Pretax Income	-850.1	-4,704.27	5,449	4,918	2,261
Income Tax	-212.78	-1,076.74	1,195	1,104	502.41
Net Income	-637.32	-3,627.54	4,254	3,814	1,759
Net Income Growth	-	-	11.54%	116.88%	381.02%
Shares Outstanding (Basic)	29	30	30	30	30
Shares Outstanding (Diluted)	29	30	30	30	30
Shares Change	-1.93%	-1.40%	0.16%	-0.08%	-0.15%
EPS (Basic)	-21.82	-121.79	142.61	128.13	58.93
EPS (Diluted)	-21.82	-121.79	140.83	126.47	58.27
EPS Growth	-	-	11.35%	117.04%	381.57%
Free Cash Flow	218.47	81.83	535.77	476.48	359.49
Free Cash Flow Per Share	7.48	2.75	17.96	16.01	12.05
Gross Margin	53.42%	55.93%	56.05%	56.48%	54.38%
Operating Margin	12.65%	17.22%	17.12%	16.55%	9.93%
Profit Margin	-23.86%	-129.45%	145.57%	149.83%	76.08%
Free Cash Flow Margin	8.18%	2.92%	18.33%	18.72%	15.55%
Effective Tax Rate	-	-	21.93%	22.44%	22.22%
EBITDA	-800.67	-4,666.16	5,451	4,940	2,284
EBITDA Margin	-29.97%	-166.51%	186.50%	194.05%	98.82%
EBIT	-800.67	-4,666.16	5,451	4,940	2,284
EBIT Margin	-29.97%	-166.51%	186.50%	194.05%	98.82%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).